Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Looks like standard filings--still have the 17th to accept mediation

RE: Looks like standard filings--still have the 17th to accept mediation

posted on Jul 12, 2006 10:09PM
This is the rest of P.R. 3-1 (c) A chart identifying specifically where each element of each asserted claim is

found within each Accused Instrumentality, including for each element that such

party contends is governed by 35 U.S.C. § 112(6), the identity of the structure(s),

act(s), or material(s) in the Accused Instrumentality that performs the claimed

function;

(d) Whether each element of each asserted claim is claimed to be literally present or

present under the doctrine of equivalents in the Accused Instrumentality;

(e) For any patent that claims priority to an earlier application, the priority date to

which each asserted claim allegedly is entitled; and

(f) If a party claiming patent infringement wishes to preserve the right to rely, for any

purpose, on the assertion that its own apparatus, product, device, process, method,

act, or other instrumentality practices the claimed invention, the party must identify,

separately for each asserted claim, each such apparatus, product, device, process,

method, act, or other instrumentality that incorporates or reflects that particular

claim.

Share
New Message
Please login to post a reply